- Home
- SQNS vs ICCM Comparison
SQNS vs ICCM Comparison
Compare SQNS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SQNS | ICCM |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | France | Israel |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.0M | 41.4M |
| IPO Year | 2011 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SQNS | ICCM |
|---|---|---|
| Price | $2.53 | $0.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $20.33 | $2.50 |
| AVG Volume (30 Days) | 76.0K | ★ 732.5K |
| Earning Date | 05-05-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | $62.85 | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $0.28 |
| 52 Week High | $10.93 | $1.40 |
Technical Indicators
Market Signals| Indicator | SQNS | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 32.75 | 24.53 |
| Support Level | $1.23 | N/A |
| Resistance Level | $3.27 | $0.74 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 7.53 | 5.67 |
Price Performance
Historical ComparisonAbout SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.